Hyperfractionation: where do we stand?
- 1 April 1997
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 43 (1) , 1-21
- https://doi.org/10.1016/s0167-8140(97)01911-7
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Rebuttal: Is gambling a serious alternative to evidence-based medicine?Radiotherapy and Oncology, 1995
- White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (radiation therapy oncology group 83-02)Cancer, 1994
- Inoperable non-small cell lung cancer: A retrospective analysis of 427 patients treated with high-dose radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- What has radiation biology contributed to the evolution of radiotherapy?European Journal of Cancer and Clinical Oncology, 1991
- Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- Radiotherapy of the rhabdomyosarcoma R1H of the rat: Hyperfractionation—126 fractions applied within 6 weeksInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trialCancer, 1982
- Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approachCancer, 1981
- Multiple daily fractionation in radiotherapy: Biological rationale and preliminary clinical experiencesPublished by Elsevier ,1979
- Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV X-rays: II. Effects of fractionated treatments, applied five times a week for several weeksPublished by Elsevier ,1970